Clinical Trial Update: Evaluation of the Performance of the Cardiolens® Platform, Which Utilizes a Non-Invasive Combined Anatomical and Functional CCTA-based Assessment in Patients With Suspected CCS

View source ↗

Summary

The study evaluated the performance of the Cardiolens Platform, a non-invasive CCTA-based assessment for suspected chronic coronary syndrome, and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Cardiolens Platform

Snippet

Sponsor: Hemolens Diagnostics Sp. z o.o. | Conditions: Chronic Coronary Syndrome | Status: COMPLETED